Crystal meth is the single biggest risk factor for HIV seroconversion among gay men in US study
PrEP in Europe webinar
Adult doses of dolutegravir can be used by children weighing 20 kg or more
HIV programmes in Africa need new models of care for people’s first six months on treatment
No increased risk of diabetes with integrase inhibitors in people starting HIV treatment
India progresses towards eliminating vertical transmission of HIV but is not there yet
A third of people living with HIV have not discussed U=U with their healthcare provider
Why do people in southern Africa stop taking PrEP?
Trans and cis women and men all have similar levels of PrEP drugs in blood, directly observed dosing study finds
